Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
UTMD · NASDAQ · Surgical & Medical Instruments & Apparatus
Utah Medical Products (UTMD) · oqro.io/stocks/UTMD · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$71.97−1.66 (−2.25%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
3 routine filings (option exercises, shares withheld for taxes, grants, gifts) are not listed here. Show them
Insider buying
First insider buy since Aug 2011Traded Oct 29 · filed the same day
Since the trade +7.7% · S&P 500 −1.9% · to Nov 13
The CEO of Utah Medical Products paid $67K out of pocket for Utah Medical Products shares.
1 open-market purchase and 0 open-market sales by insiders of UTMD between Dec 30, 2025 and today, placed against the company's last 4 earnings releases. The latest on file was filed Oct 22, 2026. The data provider lists the next release for Jan 27, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Oct 22, 2026 | None | None | 1 purchase |
| Jul 23, 2026 | None | None | None |
| Apr 23, 2026 | None | None | None |
| Jan 29, 2026 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies
